Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcome-Reference-Cited by-同舟云学术

Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcome

Published:1995-03 Issue:3 Volume:45 Page:476-483
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Zagars Gunar K.,Pollack Alan

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Status of radiation treatment of prostate cancer at Stanford University;Bagshaw;Natl Cancer Inst Monogr,1988

2. External-beam radiation therapy for clinically localized prostate cancer: patterns of care studies in the United States;Hanks;Natl Cancer Inst Monogr,1988

3. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate;Zagars;Int J Radiat Oncol Biol Phys,1988

4. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy;Zagars;Cancer,1993

5. Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment;Swanson;Br J Radiol,1994

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and high-risk prostate cancer;Advances in Radiation Oncology;2016-10

2. Interpretation of PSA levels after radical therapy for prostate cancer;Trends in Urology & Men's Health;2014-07

3. Cinétique de PSA après radiothérapie;Annales de biologie clinique;2009-07

4. Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study;Clinical and Translational Oncology;2009-05

5. Race-specific reference ranges of serum prostate-specific antigen levels in countries with a low incidence of prostate cancer;BJU International;2006-01